NEW YORK (Reuters Health) – HER2 protein and gene expression predict the response of breast cancer patients to adjuvant trastuzumab therapy, but which test provides the best information?…
NEW YORK (Reuters Health) – The 10-year outcomes data from the MASS II trial comparing coronary artery bypass grafting (CABG), percutaneous coronary intervention (PCI) and medical treatment for…
NEW YORK (Reuters Health) – Extracorporeal shock wave lithotripsy (SWL) is safe for treating kidney stones in children, with no impact on kidney function, prospective study results suggest.…
NEW YORK (Reuters Health) – A cervical cancer prevention trial conducted in South Africa shows that a single test for human papillomavirus (HPV) infection followed by cryotherapy in…
NEW YORK (Reuters Health) – Cardiac resynchronization therapy for a year improves cardiac size and performance in patients with mildly symptomatic heart failure, resulting in improved outcomes, according…
NEW YORK (Reuters Health) – Patients with an acute coronary syndrome referred for invasive treatment have similar outcomes whether they are given double-dose or standard-dose clopidogrel plus higher-dose…
NEW YORK (Reuters Health) – By lowering heart rate, the selective sinoatrial current inhibitor ivabradine improves outcomes in patients with chronic heart failure and an elevated heart rate,…
NEW YORK (Reuters Health) – Men undergoing androgen deprivation therapy for prostate cancer halve their risk of vertebral fractures if they take the selective estrogen receptor modulator toremifene…
NEW YORK (Reuters Health) – While clopidogrel’s effectiveness in the treatment of acute coronary syndromes is affected by a patient’s genotype, the efficacy of ticagrelor is not. Therefore,…
